A review on post-operative complications and its care after cataract surgery
A cataract is a clouding of the natural intraocular crystalline lens that focuses the light entering the eye onto the retina. This cloudiness can cause a decrease in vision and may lead to eventual blindness if left untreated. Cataracts often develop slowly and painlessly, so vision and lifestyle can be affected without a person realizing it. Worldwide, cataracts are the number one cause of preventable blindness. Modern cataract surgery, which is the removal of the cloudy lens and implantation of a clear intraocular lens (IOL), is the only definitive treatment for Cataracts often develops slowly with a gradual decline in vision that cannot be corrected with glasses. Common complaints include blurry vision, difficulty reading in dim light, and poor vision at night, glare and halos around lights, and occasionally double vision. Other signs of cataracts include frequent changes in the prescription of glasses and a new ability to read without reading glasses in patients over 55. There are several types of cataract including age related, traumatic, and metabolic. Age related is the most common type and the pathogenesis is multifactorial and not fully understood. A traumatic cataract can occur following both blunt and penetrating eye injuries as well as after electrocution, chemical burns, and exposure to radiation. Metabolic cataracts occur in uncontrolled diabetics, patients with galactosemia, Wilson disease, and Myotonic dystrophy.
2. Gilliland GD, Hutton WL, Fuller DG. Retained intravitreal lens fragments after cataract surgery. Ophthalmology 1992; 99:1263-7.
3. Scott IU, Flynn HW Jr. Smiddy WE, et al. Clinical features and outcomes of pars plana vitrectomy in patients with retained lens fragments. Ophthalmology 2003; 110:1567-72.
4. Eifrig CW, Flynn HW Jr., Scott IU, Newton J. Acute-onset postoperative endophthalmitis: Review of incidence and visual outcomes (1995-2001). Oph-thalmic Surg Lasers 2002; 33:373-8.
5. Nagaki Y, Hayasaka S, Kadoi C, et al. Bacterial end-ophthalmitis after small-incision cataract surgery. effect of incision placement and intraocular lens type. J Cataract Refract Surg 2003; 29:20-6.
6. Ciulla TA, Starr MB, Masket S. Bacterial endophthalmitis prophylaxis for cataract surgery: an evidence-based update. Ophthalmology 2002; 109:13-24.
7. Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Endophthalmitis Vitrectomy Study Group. Arch Ophthalmol 1995; 113:1479-96.
8. Kim JE, Flynn HW, Jr., Rubsamen PE, et al. Endoph-thalmitis in patients with retained lens fragments after phacoemulsification. Ophthalmology 1996; 103:575-8.
9. Sunaric-Megevand G, Pournaras CJ. Current ap-proach to postoperative endophthalmitis. Br J Oph thalmol 1997; 81:1006-15.
10. Aasuri MK, Kompella VB, Majji AB. Risk factors for and management of dropped nucleus during phacoemulsification. J Cataract Refract Surg 2001; 27:1428-32.
11. Allan BD. Mechanism of iris prolapsed, A qualitative analysis and implications for surgical technique. J Cataract Refract Surg. 1995; 21(2):182-186.
12. Mammalis N, Edelhauser HF, Dawson DG, Chew J, LeBoyer RM, Werner L. Toxic anterior segment syndrome. J Cataract Refract Surg 2006; 32:324.
13. Holland SP, Morck DW, Lee TL. Update on toxic anterior segment syndrome. Curr Opin Ophthalmol 2007;18:4.
14. Research Team. Arch Ophthalmol 1994;112:239-52.
15. Flach AJ. The incidence, pathogenesis and treatment of cystoid macular edema following cataract surgery. Trans Am Ophthalmol Soc 1998; 96:557-634.
16. Heier JS, Topping TM, Baumann W, et al. Ketorolac versus prednisolone versus combination therapy in the treatment of acute pseudophakic cystoid macular edema. Ophthalmology 2000; 107:2034-8.
17. Benhamou N, Massin P, Haouchine B, et al. In-travitreal triamcinolone for refractory pseudophakic macular edema. Am J Ophthalmol 2003; 135:246-9.
18. Ursell PG, Spalton DJ, Pande MV, et al. Relationship between intraocular lens biomaterials and posterior capsule opacification. J Cataract Refract Surg 1998; 24:352–60.
19. Spalton DJ. Posterior capsular opacification after cataract surgery. Eye 1999; 13(Pt 3b):489–92.
20. Post operative care, http://www.sankaranethralaya.org/.
Copyright © Author(s) retain the copyright of this article.